drugset / Trial / NCT03574142
A Ph 1 Study of Epanova® in Healthy Chineses
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to explore the safety, tolerability, and PK of single and multiple doses of Epanova in healthy male and female Chinese subjects and to allow comparison of these parameters with the Western population studied to date.
Timeline
- Start
- 2018-06-04
- Primary completion
- 2018-06-27
- Completion
- 2018-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epanova | Other / unclassified | 4 g | Oral |
Indications
No indication recorded.